{"id":"https://openalex.org/W4407416640","doi":"https://doi.org/10.3390/pharmaceutics17020239","title":"Uptake and Inhibition of P-Glycoprotein-Mediated Efflux Evaluation of Encapsulated Methotrexate Chitosan and Hypromellose Phthalate Nanoparticles for Potential Glioblastoma Treatment","display_name":"Uptake and Inhibition of P-Glycoprotein-Mediated Efflux Evaluation of Encapsulated Methotrexate Chitosan and Hypromellose Phthalate Nanoparticles for Potential Glioblastoma Treatment","publication_year":2025,"publication_date":"2025-02-12","ids":{"openalex":"https://openalex.org/W4407416640","doi":"https://doi.org/10.3390/pharmaceutics17020239","pmid":"https://pubmed.ncbi.nlm.nih.gov/40006606"},"language":"en","primary_location":{"id":"doi:10.3390/pharmaceutics17020239","doi":"https://doi.org/10.3390/pharmaceutics17020239","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics17020239","pdf_url":"https://www.mdpi.com/1999-4923/17/2/239/pdf?version=1739352645","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/1999-4923/17/2/239/pdf?version=1739352645","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014554708","display_name":"Val\u00e9ria de Moura Leite Naves","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I23925101","display_name":"Universidade Federal de Alfenas","ror":"https://ror.org/034vpja60","country_code":"BR","type":"education","lineage":["https://openalex.org/I23925101"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Val\u00e9ria de Moura Leite Naves","raw_affiliation_strings":["Department of Food and Drugs, Federal University of Alfenas, UNIFAL-MG, Alfenas 37130-001, MG, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Food and Drugs, Federal University of Alfenas, UNIFAL-MG, Alfenas 37130-001, MG, Brazil","institution_ids":["https://openalex.org/I23925101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023992147","display_name":"Rafaela Franco Dias Bruzadelli","orcid":"https://orcid.org/0000-0001-6415-6707","observed_orcids":["https://orcid.org/0000-0001-6415-6707"]},"institutions":[{"id":"https://openalex.org/I23925101","display_name":"Universidade Federal de Alfenas","ror":"https://ror.org/034vpja60","country_code":"BR","type":"education","lineage":["https://openalex.org/I23925101"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Rafaela Franco Dias Bruzadelli","raw_affiliation_strings":["Department of Food and Drugs, Federal University of Alfenas, UNIFAL-MG, Alfenas 37130-001, MG, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Food and Drugs, Federal University of Alfenas, UNIFAL-MG, Alfenas 37130-001, MG, Brazil","institution_ids":["https://openalex.org/I23925101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019563763","display_name":"Marisa Ionta","orcid":"https://orcid.org/0000-0001-8796-1426","observed_orcids":["https://orcid.org/0000-0001-8796-1426"]},"institutions":[{"id":"https://openalex.org/I23925101","display_name":"Universidade Federal de Alfenas","ror":"https://ror.org/034vpja60","country_code":"BR","type":"education","lineage":["https://openalex.org/I23925101"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Marisa Ionta","raw_affiliation_strings":["Institute of Biomedicals Sicences, Federal University of Alfenas, UNIFAL-MG, Alfenas 37130-001, MG, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Biomedicals Sicences, Federal University of Alfenas, UNIFAL-MG, Alfenas 37130-001, MG, Brazil","institution_ids":["https://openalex.org/I23925101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019832099","display_name":"Maria Palmira Daflon Gremi\u00e3o","orcid":"https://orcid.org/0000-0001-6950-7852","observed_orcids":["https://orcid.org/0000-0001-6950-7852"]},"institutions":[{"id":"https://openalex.org/I879563668","display_name":"Universidade Estadual Paulista (Unesp)","ror":"https://ror.org/00987cb86","country_code":"BR","type":"education","lineage":["https://openalex.org/I879563668"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Maria Palmira Daflon Gremi\u00e3o","raw_affiliation_strings":["Department of Drugs and Medicines, School of Pharmaceutical Sciences, State University of S\u00e3o Paulo State, UNESP, Araraquara 14800-903, SP, Brazil"],"raw_orcid":"https://orcid.org/0000-0001-6950-7852","affiliations":[{"raw_affiliation_string":"Department of Drugs and Medicines, School of Pharmaceutical Sciences, State University of S\u00e3o Paulo State, UNESP, Araraquara 14800-903, SP, Brazil","institution_ids":["https://openalex.org/I879563668"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078861093","display_name":"Liliane Neves Pedreiro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I879563668","display_name":"Universidade Estadual Paulista (Unesp)","ror":"https://ror.org/00987cb86","country_code":"BR","type":"education","lineage":["https://openalex.org/I879563668"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Liliane Neves Pedreiro","raw_affiliation_strings":["Department of Drugs and Medicines, School of Pharmaceutical Sciences, State University of S\u00e3o Paulo State, UNESP, Araraquara 14800-903, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drugs and Medicines, School of Pharmaceutical Sciences, State University of S\u00e3o Paulo State, UNESP, Araraquara 14800-903, SP, Brazil","institution_ids":["https://openalex.org/I879563668"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071040572","display_name":"Gislaine Ribeiro Pereira","orcid":"https://orcid.org/0000-0003-2293-7868","observed_orcids":["https://orcid.org/0000-0003-2293-7868"]},"institutions":[{"id":"https://openalex.org/I23925101","display_name":"Universidade Federal de Alfenas","ror":"https://ror.org/034vpja60","country_code":"BR","type":"education","lineage":["https://openalex.org/I23925101"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Gislaine Ribeiro Pereira","raw_affiliation_strings":["Department of Food and Drugs, Federal University of Alfenas, UNIFAL-MG, Alfenas 37130-001, MG, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Food and Drugs, Federal University of Alfenas, UNIFAL-MG, Alfenas 37130-001, MG, Brazil","institution_ids":["https://openalex.org/I23925101"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073848896","display_name":"Fl\u00e1via Chiva Carvalho","orcid":"https://orcid.org/0000-0001-7586-539X","observed_orcids":["https://orcid.org/0000-0001-7586-539X"]},"institutions":[{"id":"https://openalex.org/I23925101","display_name":"Universidade Federal de Alfenas","ror":"https://ror.org/034vpja60","country_code":"BR","type":"education","lineage":["https://openalex.org/I23925101"]}],"countries":["BR"],"is_corresponding":true,"raw_author_name":"Fl\u00e1via Chiva Carvalho","raw_affiliation_strings":["Department of Food and Drugs, Federal University of Alfenas, UNIFAL-MG, Alfenas 37130-001, MG, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Food and Drugs, Federal University of Alfenas, UNIFAL-MG, Alfenas 37130-001, MG, Brazil","institution_ids":["https://openalex.org/I23925101"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5073848896"],"corresponding_institution_ids":["https://openalex.org/I23925101"],"apc_list":{"value":2900,"currency":"CHF","value_usd":3499},"apc_paid":{"value":2900,"currency":"CHF","value_usd":3499},"fwci":0.3699,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.42771658,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":96},"biblio":{"volume":"17","issue":"2","first_page":"239","last_page":"239"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.8070999979972839,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.8070999979972839,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.1793999969959259,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.00839999970048666,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9980000257492065},{"id":"https://openalex.org/keywords/chitosan-nanoparticles","display_name":"chitosan nanoparticles","score":0.8309999704360962},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9660000205039978},{"id":"https://openalex.org/keywords/drug-delivery","display_name":"drug delivery","score":0.382999986410141},{"id":"https://openalex.org/keywords/polyelectrolyte-complexation","display_name":"polyelectrolyte complexation","score":0.890999972820282},{"id":"https://openalex.org/keywords/mucoadhesion","display_name":"mucoadhesion","score":0.9509999752044678},{"id":"https://openalex.org/keywords/controlled-drug-release","display_name":"controlled drug release","score":0.8679999709129333},{"id":"https://openalex.org/keywords/encapsulation-efficiency","display_name":"encapsulation efficiency","score":0.75},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.7139999866485596},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.4169999957084656}],"concepts":[{"id":"https://openalex.org/C200082930","wikidata":"https://www.wikidata.org/wiki/Q22327148","display_name":"Efflux","level":2,"score":0.7669677734375},{"id":"https://openalex.org/C2779732960","wikidata":"https://www.wikidata.org/wiki/Q408510","display_name":"Chitosan","level":2,"score":0.7552440762519836},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.6608368158340454},{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.6289793252944946},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6267894506454468},{"id":"https://openalex.org/C2781005124","wikidata":"https://www.wikidata.org/wiki/Q84483575","display_name":"Phthalate","level":2,"score":0.5228329300880432},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.49668270349502563},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45335519313812256},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.448800653219223},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.4447842538356781},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.29693034291267395},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.24607554078102112},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2374250292778015},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.19362711906433105},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.17143133282661438},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.15604010224342346},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.1326194703578949},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12267163395881653},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.11639058589935303},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3390/pharmaceutics17020239","doi":"https://doi.org/10.3390/pharmaceutics17020239","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics17020239","pdf_url":"https://www.mdpi.com/1999-4923/17/2/239/pdf?version=1739352645","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:40006606","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40006606","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11859166","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11859166","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11859166/pdf/pharmaceutics-17-00239.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceutics","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:973aec323f0d4739b7f5155034703296","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/973aec323f0d4739b7f5155034703296","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceutics, Vol 17, Iss 2, p 239 (2025)","raw_type":"article"},{"id":"pmh:oai:repositorio.unesp.br:11449/298695","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/11449/298695","pdf_url":null,"source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"instacron:UNESP","raw_type":"info:eu-repo/semantics/publishedVersion"}],"best_oa_location":{"id":"doi:10.3390/pharmaceutics17020239","doi":"https://doi.org/10.3390/pharmaceutics17020239","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics17020239","pdf_url":"https://www.mdpi.com/1999-4923/17/2/239/pdf?version=1739352645","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[{"id":"https://openalex.org/G1508798716","display_name":null,"funder_award_id":"454679/2014-9","funder_id":"https://openalex.org/F4320322025","funder_display_name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico"},{"id":"https://openalex.org/G6649010465","display_name":null,"funder_award_id":"1241/2014","funder_id":"https://openalex.org/F4320321091","funder_display_name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior"},{"id":"https://openalex.org/G7798892703","display_name":null,"funder_award_id":"CDS\u00a0APQ\u00a000465/14","funder_id":"https://openalex.org/F4320322980","funder_display_name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais"}],"funders":[{"id":"https://openalex.org/F4320321091","display_name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","ror":"https://ror.org/00x0ma614"},{"id":"https://openalex.org/F4320322025","display_name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","ror":"https://ror.org/03swz6y49"},{"id":"https://openalex.org/F4320322980","display_name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","ror":"https://ror.org/00nc55f03"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4407416640.pdf","grobid_xml":"https://content.openalex.org/works/W4407416640.grobid-xml"},"referenced_works_count":44,"referenced_works":["https://openalex.org/W1823279151","https://openalex.org/W1965973983","https://openalex.org/W1970634151","https://openalex.org/W1971645600","https://openalex.org/W1977470111","https://openalex.org/W1982974605","https://openalex.org/W1991517006","https://openalex.org/W1993666998","https://openalex.org/W2006845797","https://openalex.org/W2009344459","https://openalex.org/W2010099401","https://openalex.org/W2016543419","https://openalex.org/W2016889033","https://openalex.org/W2017137997","https://openalex.org/W2021124448","https://openalex.org/W2021900697","https://openalex.org/W2025864326","https://openalex.org/W2029738042","https://openalex.org/W2033025383","https://openalex.org/W2035622303","https://openalex.org/W2049688474","https://openalex.org/W2052254665","https://openalex.org/W2066854232","https://openalex.org/W2079407952","https://openalex.org/W2080631589","https://openalex.org/W2083857325","https://openalex.org/W2089595610","https://openalex.org/W2102131116","https://openalex.org/W2135396719","https://openalex.org/W2138426564","https://openalex.org/W2154186431","https://openalex.org/W2161152672","https://openalex.org/W2165807036","https://openalex.org/W2171475781","https://openalex.org/W2319498377","https://openalex.org/W2321059605","https://openalex.org/W2365404599","https://openalex.org/W2409321279","https://openalex.org/W2409603104","https://openalex.org/W2480650804","https://openalex.org/W2592391609","https://openalex.org/W2744921393","https://openalex.org/W2770800010","https://openalex.org/W3186689016"],"related_works":["https://openalex.org/W4294636674","https://openalex.org/W2501597952","https://openalex.org/W1971121351","https://openalex.org/W2007858153","https://openalex.org/W4229457406","https://openalex.org/W2317193739","https://openalex.org/W4389166157","https://openalex.org/W2129149779","https://openalex.org/W1510465827","https://openalex.org/W2077865136"],"abstract_inverted_index":{"Background:":[0],"Methotrexate":[1],"(MTX),":[2],"a":[3,109,116],"folic":[4],"acid":[5],"antagonist":[6],"used":[7,93],"in":[8,74,159],"chemotherapy,":[9],"faces":[10],"limitations":[11],"due":[12],"to":[13,35,94,142,171],"cancer":[14],"cell":[15,44],"resistance,":[16],"high":[17],"toxicity,":[18],"and":[19,31,46,59,72,82,87,97,115,124,188,194],"low":[20],"bioavailability.":[21],"Objective:":[22],"This":[23],"study":[24],"developed":[25],"nanoparticles":[26],"(NPs)":[27],"of":[28,112,119,138,164,203],"chitosan":[29],"(QS)":[30],"hydroxypropylmethylcellulose":[32],"phthalate":[33],"(HPMCP)":[34],"encapsulate":[36],"MTX":[37,144,173],"for":[38,205],"potential":[39,118,202],"effect":[40],"investigation":[41],"on":[42,181],"glioblastoma":[43,96,206],"targeting":[45],"P-gp":[47,99,195],"efflux":[48,100],"inhibition.":[49,196],"Method:":[50],"NPs":[51],"were":[52,60,92],"produced":[53],"by":[54,62],"the":[55,98,127,201],"polyelectrolyte":[56],"complexation":[57],"method":[58],"characterized":[61],"DLS,":[63],"PDI,":[64],"DSC,":[65,122],"FTIR,":[66,123],"PXRD,":[67],"MEV,":[68],"drug":[69,152],"release":[70,148,153],"profile,":[71],"an":[73],"vitro":[75,147],"mucoadhesion":[76,133],"test.":[77],"Cell":[78],"viability,":[79],"flow":[80],"cytometry,":[81],"LSCM":[83,189],"using":[84],"U251MG":[85,160],"(glioblastoma)":[86],"CCD":[88],"1059Sk":[89],"(fibroblasts)":[90],"cells":[91],"evaluate":[95],"effect.":[101],"Results:":[102],"NPPM29":[103,139,165],"(QS3:1)":[104],"showed":[105],"91.72%":[106],"encapsulation":[107],"efficiency,":[108],"mean":[110],"diameter":[111],"452.6":[113],"nm,":[114],"zeta":[117],"+22.5":[120],"mV.":[121],"PXRD":[125],"confirmed":[126,190],"QS-HPMCP":[128],"supramolecular":[129],"interaction.":[130],"Liquid":[131],"falling":[132],"tests":[134],"demonstrated":[135],"strong":[136],"retention":[137],"(84%)":[140],"compared":[141,170],"free":[143,172],"(10.5%).":[145],"In":[146],"studies":[149],"indicated":[150],"controlled":[151],"at":[154],"pH":[155],"7.4.":[156],"Cytotoxicity":[157],"assays":[158],"revealed":[161],"enhanced":[162],"efficacy":[163],"(IC50":[166,174],"=":[167,175],"68.79":[168],"\u00b5g/mL)":[169],"80.54":[176],"\u00b5g/mL),":[177],"with":[178],"minimal":[179],"impact":[180],"fibroblasts,":[182],"confirming":[183],"tumor":[184],"specificity.":[185],"Flow":[186],"cytometry":[187],"improved":[191],"cellular":[192],"internalization":[193],"Conclusions:":[197],"These":[198],"findings":[199],"highlight":[200],"MTX-QS-HPMCP-NPs":[204],"therapy.":[207]},"counts_by_year":[{"year":2025,"cited_by_count":2}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-02-13T00:00:00"}